Central Nervous System Sarcoma
NCI Definition: A sarcoma that arises from the central nervous system. 
There are 2 clinical trials for central nervous system sarcoma, of which 1 is open and 1 is completed or closed. Of the trials that contain central nervous system sarcoma as an inclusion criterion, 2 are phase 2 (1 open).
Nivolumab and sunitinib are the most common interventions in central nervous system sarcoma clinical trials.
Significant Genes in Central Nervous System Sarcoma
H3F3A is an inclusion eligibility criterion in 1 clinical trial for central nervous system sarcoma, of which 1 is open and 0 are closed. Of the trial that contains H3F3A status and central nervous system sarcoma as inclusion criteria, 1 is phase 2 (1 open) .
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.